comparemela.com
Home
Live Updates
Aldeyra Therapeutics Provides Clinical and Regulatory Update
Aldeyra Therapeutics Provides Clinical and Regulatory Update
Aldeyra Therapeutics Provides Clinical and Regulatory Update and Announces Advancement of RASP Platform in Systemic and Retinal Inflammatory Diseases
Based on positive biomarker results observed in adult cohort of Phase 2 clinical trial of ADX-629 in Sjögren-Larsson Syndrome, proposed expansion to include pediatric patients expected to be...
Related Keywords
United States ,
Ptoddc Brady ,
,
Aldeyra Therapeutics Inc ,
Nasdaq ,
Exchange Commission ,
Securities Exchange ,
Aldeyra Therapeutics ,
Larsson Syndrome ,
Chief Executive Officer ,
Special Protocol Assessment ,
Private Securities Litigation Reform Act ,
Securities Exchange Act ,
Financial Condition ,
Annual Report ,
Quarterly Report ,
Markets ,